Skip to Main Content

Paper Details

Preventing asthma in high risk kids (PARK) with omalizumab: Design, rationale, methods, lessons learned and adaptation.
Contemp Clin Trials
21
2021
Author NameAffiliation
Daniel J JacksonUniversity of Wisconsin
Anne M FitzpatrickEmory University
Lisa M WheatleyNIH/National Institute of Allergy and Infectious Diseases
Jacqueline A PongracicAnn and Robert Lurie Children's Hospital of Chicago
Stephen J TeachChildren's National Hospital
Peggy S LaiHarvard Medical School, United States of America Massachusetts General Hospital
  • 1 - 6

Datasets

Release 1.2